Search…

The concept of innovative drugs is resurfacing, Keye Technology's stock rose more than 10%

25/07/2025

In early trading, the concept of innovative medicines is repeatedly active, Keye Technology rose more than 10%, Nanjing New Bai had two consecutive limit up, Lianhuan Pharmaceuticals, Microcore Biosciences, Ditze Medicine, Shutaishen, Kailaiying, etc. also rose.

Latest

1 m ago

Shenghualand Holdings Limited (08106.HK) controlling shareholder plans to change hands and will receive approximately 20.20% of the full acquisition offer from Shanghai Xinhua and Cloud Odd. The resumption of trading will take place on July 28th.

4 m ago

U.S. stock market anomaly | Linkhome (LHAI.US), a newly listed stock, once rose nearly 130% and triggered another trading halt.

4 m ago

Medical research and drug development company Sarepta Therapeutics Inc. fell by more than 13.66% at one point, leading to a cumulative decline of over 20.96% in the past five trading days. An advisory committee of the European Medicines Agency has recommended against approving the company's gene therapy Elevidys.

5 m ago

The Ministry of Industry and Information Technology will accelerate the construction of the open source system.

6 m ago

Trump hints that the Federal Reserve may cut interest rates.

See all latest